The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action

Molecular Aspects of Medicine

Volumn 29, Issue 6, 2008, Pages 361-368

  Holick, Michael F ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Mechanism of action; Nonskeletal health; Pandemic and consequences; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; VITAMIN D; VITAMIN D RECEPTOR;

ANTINEOPLASTIC ACTIVITY; CALCIUM METABOLISM; CANCER CELL CULTURE; CANCER RISK; CROHN DISEASE; DIETARY INTAKE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NONHUMAN; PANDEMIC; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; ULTRAVIOLET A RADIATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ANIMALS; AUTOIMMUNE DISEASES; BONE DISEASES; CARDIOVASCULAR DISEASES; DISEASE OUTBREAKS; HEALTH; HUMANS; VITAMIN D DEFICIENCY;

EID: 56149109009     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2008.08.008     Document Type: Review

References (75)

1. Abbas S., Linseisen J., Slanger T., Kropp S., Mutschelknauss E.J., Flesch-Janys D., and Chang-Claude J. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large case-control study. Carcinogenesis 29 1 (2008) 93-99
2. Adams J.S., Gacad M.A., Anders A., Endres D.B., and Sharma O.P. Biochemical indicators of disordered vitamin D and calcium homeostasis in sarcoidosis. Sarcoidosis 3 (1986) 1-6
3. Adams J.S., and Hewison M. Hypercalcemia caused by granuloma-forming disorders. In: Favus M.J. (Ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. sixth ed. (2006), American Society for Bone and Mineral Research, Washington, DC 200-202
4. Aloia J.R., and Li-Ng M. Epidemic influenza and vitamin D. Epidemiol. Infect. 12 (2007) 1-4
5. Beer T.M., Ryan C.W., Venner P.M., Petrylak D.P., Chatta G.S., Ruether J.D., Redfern C.H., Fehrenbacher L., Saleh M.N., Waterhouse D.M., Carducci M.A., Vacario D., Dreicer R., Higano C.S., Ahmann F.R., Chi K.N., Henner W.D., Arroyo A., and Clow F.W. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT investigators. J. Clin. Oncol. 25 (2007) 669-674
6. Bikle D.D. Vitamin D: role in skin and hair. In: Feldman, et al. (Ed). Vitamin D (2005), Elsevier Academic Press, New Jersey 609-630
7. Bouillon R., Okamura W.H., and Norman A.W. Structure-function relationships in the vitamin D endocrine system. Endocrine Rev. 16 (1995) 200-257
8. Brot C., Vestergaard P., Kolthoff N., Gram J., Hermann A.P., and Sorensen O.H. Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br. J. Nutr. 86 1 (2001) S97-S103
9. Camargo Jr. C.A., Rifas-Shiman S.L., Litonjua A.A., Rich-Edwards J.W., Weiss S.T., Gold D.R., and Gillman M.W. Prospective study of maternal intake of vitamin D during pregnancy and risk of wheezing illnesses in children at age 2 years. J. Allergy Clin. Imunol. 117 (2006) 721-722
10. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., Garland C.F., and Giovannucci E. Epidemic influenza and vitamin D. Epidemiol. Infect. 134 6 (2006) 1129-1140
11. Carbone L.D., Rosenberg E.W., Tolley E.A., Holick M.F., Hughes T.A., Watsk M.A., Barrow K.D., Chen T.C., Wilkin N.K., Bhattacharya S.K., Dowdy J.C., Sayre R.M., and Weber K.T. 25-Hydroxyvitamin D, cholesterol, and ultraviolet irradiation. Metab. Clin. Exp. 57 (2008) 741-748
12. Chen T.C., and Holick M.F. Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol. Metab. 14 (2003) 423-430
13. Cigolini M., Iagulli M.P., Miconi V., Galiotto M., Lombard i.S., and Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29 (2006) 722-724
14. 3-1-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66 (2001) 287-292
15. Diesel B., Radermacher J., Bureik M., Bernhardt R., Seifert M., Reichrath J., Fischer U., and Meese E. Vitamin D3 metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol. Clin. Cancer Res. 11 15 (2005) 5370-5380
16. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., Kinkeldei J., Boehm B.O., Weihrauch G., and Maerz W. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihyroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 168 12 (2008) 1340-1349
17. Embry A.F., Snowdon L.R., and Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann. Neurol. 48 (2000) 271-272
18. Feldman D., Zhao X.Y., and Krishnan A.V. Editorial/mini-review: vitamin D and prostate cancer. Endocrinology 141 (2000) 5-9
19. Flanagan J.N., Whitlatch L.W., Rudoph T., Xuehong P., Kong X., Chen T.C., and Holick M.F. Development of gene therapy with the 25-OH-1-α-hydroxylase gene: in vitro and in vivo enhancement of 1-α-hydroxylase activity in cultured prostate cancer cells and in the skin of mice. J. Bone Miner. Res. 14 (1999) 1145
20. Gauzzi M.C., Purificato C., Donato K., Jin X., Wang L., Daniel K.C., Maghazachi A.A., Belardelli F., Adorini L., and Gessani S. Suppressive effect of 1α,25-dihydroxyvitamin D3 on type 1 IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J. Immunol. 174 (2005) 270-276
21. Giovannucci E., Liu Y., and Willett W.C. Cancer incidence and mortality and vitamin D in black ad white male health professionals. Cancer Epidemiol. Biomarkers Prev. 15 12 (2006) 2467-2472
22. Gordon C.M., Feldman H.A., Sinclair L., Williams A.L., Kleinman P.K., Perez-Rossello J., and Cox J.E. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch. Pediatr. Adolesc. Med. 162 6 (2008) 505-512
23. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin M., Newmark H.L., Giovannucci E., Wei M., and Holick M.F. Vitamin D and prevention of colorectal cancer. J. Steroid Biochem. Mol. Biol. 97 1-2 (2005) 179-194
24. Grant W.B. An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 94 6 (2002) 1867-1875
25. Harris S.S., Soteriades E., Coolidge J.A., Mudgal S., and Dawson-Hughes B. Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J. Clin. Endocrinol. Metab. 85 (2000) 4125-4130
26. Heaney R.P., Davies K.M., Chen T.C., Holick M.F., and Barger-Lux M.J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77 (2003) 204-210
27. Holick M.F. Vitamin D: a millennium perspective. J. Cell Biochem. 88 (2003) 296-307
28. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 79 3 (2004) 362-371
29. Holick M.F. Calcium plus vitamin D and the risk of colorectal cancer. N. Engl. J. Med. 354 21 (2006) 2287
30. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 357 (2007) 266-281
31. Holick M.F., Chen T.C., and Sauter E.R. Vitamin D and skin physiology: a D-lightful story. J. Bone Miner. Res. 22 S2 (2007) V28-V33
32. 3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J. Clin. Endocrinol. Metab. 93 3 (2008) 677-681
33. Hypponen E., Laara E., Reunanen A., Jarvelin M.R., and Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358 (2001) 1500-1503
34. Knight J.A., Lesosky M., Barnett H., Raboud J.M., and Vieth R. Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol. Biomarkers Prev. 16 3 (2007) 422-499
35. Koeffler H.P., Hirjik J., Iti L., and the Southern California Leukemia Group. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat. Rep. 69 (1985) 1399-1407
36. Kragballe K. Treatment of psoriasis by the topical application of the novel vitamin D3 analogue MC 903. Arch. Dermatol. 125 (1989) 1647-1652
37. Krause R., Buhring M., Hopfenmuller W., Holick M.F., and Sharma A.M. Ultraviolet B and blood pressure. Lancet 352 9129 (1998) 709-710
38. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., and Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85 6 (2007) 1586-1591
39. 3 is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110 2 (2002) 229-238
40. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., Bals R., Steinmeyer A., Zugel U., Gallo R.L., Eisenberg D., Hewison M., Hollis B.W., Adams J.S., Bloom B.R., and Modlin R.L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Sciencexpress 3 (2006) 1770-1773
41. Ma Y., Khalif a.B., Yee Y.K., Lu J., Mernezawa A., Savkur R.S., Yamamoto Y., Chintalacharuva S.R., Yamaoka K., Stayrook K.R., Bramlett K.S., Zeng Z.Z., Chandrasekhar S., Yu X.P., Linebarger J.H., Iturria S.T., Burris T.P., Kato S., Chin W.W., and Nagpal S. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J. Clin. Invest. 116 4 (2006) 892-904
42. 3 supplementation in school children. J. Clin. Endocrinol. Metab. doi:10.1210/jc.2007-2530.
43. Mantell D.J., Owens P.E., Bundred N.J., Mawer E.B., and Canfield A.E. 1α,25-Dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo. Circ. Res. 87 (2000) 214-220
44. Martins D., Wolf M., Pan D., Zadshir A., Tareen N., Thadhani R., Felsenfeld A., Levine B., Mehrotra R., and Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 167 (2007) 1159-1165
45. Marwaha R.K., Tandon N., Reddy D., Aggarwal R., Singh R., Sawhney R.C., Saluja B., Ganie M., and Singh S. Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am. J. Clin. Nutr. 82 (2005) 477-482
46. Mathieu C., and Adorini L. The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trend Mol. Med. 8 4 (2002) 174-179
47. Matsuoka L.Y., Ide L., Wortsman J., MacLaughlin J., and Holick M.F. Sunscreens suppress cutaneous vitamin D3 synthesis. J. Clin. Endocrinol. Metab. 64 (1987) 1165-1168
48. McAlindon T.E., Felson D.T., Zhang Y., Hannan M.T., Aliabadi P., Weissman B., Rush D., Wilson P.W., and Jacaques P. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann. Intern. Med. 125 5 (1996) 353-359
49. McKenna M.J. Differences in vitamin D status between countries in young adults and the elderly. Am. J. Med. 93 (1992) 9-77
50. Melamed M.L., Muntner P., Michos E.D., Uribarri J., Weber C., Sharma J., and Raggi P. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease. Results from NHANES 2001-2004. Arterioscler. Thromb. Vasc. Biol. 28 6 (2008) 1179-1185
51. Merlino L.A., Curtis J., Mikuls T.R., Cerhan J.R., Criswell L.A., Saag K.G., and Iowa Women's Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum. 50 1 (2004) 72-77
52. Moan J., Porojnicu A.C., Dahlback A., and Setlow R.B. Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc. Natl. Acad. Sci. USA 105 2 (2008) 668-673
53. Mohr, S.B., Garland, C.F., Gorham, E.D., Garland, F.C., 2008. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia (epub ahead of print).
54. Munger K.L., Zhang S.M., O'Reilly E., Hernan M.A., Olek M.J., Willett W.C., and Ascherio A. Vitamin D intake and incidence of multiple sclerosis. Neurology 62 1 (2004) 60-65
55. Nagpal S., Na S., and Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocrine Rev. 26 (2005) 662-687
56. Palmer H.G., Larriba M.J., Garcia J.M., Ordonez-Moran P., Pena C., Peiro S., Puig I., Rodriguez R., de la Fuente R., Bernad A., Pollan M., Bonilla F., Camallo C., Garcia de Herreros A., and Munoz A. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat. Med. 10 (2004) 917-919
57. Perez A., Chen T.C., Turner A., Raab R., Bhawan J., Poche P., and Holick M.F. Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. Br. J. Dermatol. 134 (1996) 238-246
58. Pittas A.G., Dawson-Hughes B., Li T., Van Dam R.M., Willett W.C., Manson J.E., and Hu F.B. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29 3 (2006) 650-656
59. Ponsonby A.-L., McMichael A., and van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181-182 (2002) 71-78
60. Poole K.E., Loveridge N., Barker P.J., Halsall D.J., Rose C., Reeve J., and Warburton E.A. Reduce vitamin D in acute stroke. Stroke 37 1 (2006) 243-245
61. Rostand S.G. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30 (1997) 150-156
62. 3 from 25-hydroxyvitamin D3. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 391-395
63. Scragg R., Jackson R., Holdaway I.M., Lim T., and Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int. J. Epidemiol. 19 (1990) 559-563
64. Scragg R., Sowers M., and Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am. J. Hypertens. 20 (2007) 713-719
65. Spina C.S., Tangpricha V., Uskokovic M., Adorinic L., Maehr H., and Holick M.F. Vitamin D and cancer. Anticancer Res. 26 4a (2006) 2515-2524
66. Tanaka H., Abe E., Miyaura C., Kuribayashi T., Konno K., Nishi Y., and Suda T. 1,25-Dihydroxycholeciferol and human myeloid leukemia cell line (HL-60): the presence of cytosol receptor and induction of differentiation. Biochem. J. 204 3 (1982) 713-719
67. Tangpricha V., Flanagan J.N., Whitlatch L.W., Tseng C.C., Chen T.C., Holt R.P., Lipkin M.S., and Holick M.F. 25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue. Lancet 357 9269 (2001) 1673-1674
68. Tangpricha V., Spina C., Yao M., Chen TC., Wolfe M.M., and Holick M.F. Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J. Nutr. 135 10 (2005) 2350-2354
69. Tsoukas C.D., Provvedine D.M., and Manolagas S.C. 1,25-Dihydroxyvitamin D3, a novel immuno-regulatory hormone. Science 221 (1984) 1438-1440
70. Vieth R., Bischoff-Ferrari H., Boucher B.J., Dawson-Hughes B., Garland C., Heaney R.P., Holick M.F., Hollis B.W., Lamberg-Allardt C., McGrath J.J., Norman A.W., Scragg R., Whiting S.J., Willett W.C., and Zittermann A. The urgent need to recommend an intake of vitamin D that is effective. Am. J. Clin. Nutr. 85 3 (2007) 649-650
71. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., Benjamin E.J., D'Agostino R.B., Wolf M., and Vasan R.S. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 4 (2008) 503-511
72. Whitlatch L.W., Young M.V., Schwartz G.G., Flanagan J.N., Burnstein K.L., Lokeshwar B.L., Rich E.S., Holick M.F., and Chen T.C. 25-hydroxyvitamin D-1-α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J. Steroid Biochem. Mol. Biol. 81 2 (2002) 135-140
73. Wolf, M., Shah, A., Gutierrez, O., Ankers, Monroy, M., Tamez, H., Steele, D., Chang, Y., Camargo Jr., C.A., Tonelli, M., Thadhani, R., 2007. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. doi:10.1038/sk.ki.5002451.
74. Woo T.C.S., Choo R., Jamieson M., Chander S., and Vieth R. Pilot study: potential role of vitamin D (cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr. Cancer 51 1 (2005) 32-36
75. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Biophys. Mol. Biol. 92 (2006) 39-48